跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Nirmatrelvir Tablets/Ritonavir Tablets(co-packaged)
Approved
化学药品
Nirmatrelvir Tablets/Ritonavir Tablets(co-packaged)
PFIZER LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Feb 11, 2022
Approval ID
8EflbPnDmsl
Company
PFIZER LIMITED
Type
化学药品
Approval Details
Approval Id
8EflbPnDmsl
Approval Number
国药准字HJ20220006
Generic Name
奈玛特韦片/利托那韦片组合包装
Generic Name En
Nirmatrelvir Tablets/Ritonavir Tablets(co-packaged)
Trade Name
瑞派乐
Drug Type
化学药品
Dosage Form
片剂
Strength
奈玛特韦片150mg/利托那韦片100mg
Reg Date
2022-02-11
Expired Date
2027-02-10
Company Name
PFIZER LIMITED
Company Detail Path
/organization/pfizer-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 11, 2022
Approval ID
8EflbPnDmsl
Type
化学药品
Back to NMPA Approvals
瑞派乐 - NMPA Drug Approval Details
